We are 'Little Boston' – the city of life science Göteborg

Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other industries for inspiration and knowledge.
Boubou Hallberg, Hospital Director at Sahlgrenska University Hospital and Cecilia Edebo, CEO at Sahlgrenska Science Park.
Boubou Hallberg, Hospital Director at Sahlgrenska University Hospital and Cecilia Edebo, CEO at Sahlgrenska Science Park.

Sahlgrenska University Hospital's hospital director Boubou Hallberg says that the goal is for Sahlgrenska to become Europe's leading university hospital by 2032. Sahlgrenska Science Park's new CEO Cecilia Edebo believes that the life science companies in Gothenburg can draw both competence and ideas from the most dominant industry in Western Sweden - the mobility industry.

For many people, the industrial city of Gothenburg is probably primarily synonymous with automotive development and Volvo. However, Gothenburg, or Little London as it is also known, is also home to one of the largest life science clusters in the Nordic region, employing over 10,000 people in the area. It is home to many businesses, including Astra Zeneca, Getinge and Mölnlycke Healthcare. Many companies are located close to the University of Gothenburg and the Sahlgrenska University Hospital.

Boubou Hallberg, Director of Sahlgrenska University Hospital, describes the area as ‘Little Boston’ because of the close collaboration between academia, industry and healthcare in the area, similar to that of the city of Massachusetts.

Dela detta inlägg
Skrivet av:
Håkan Oltander
Håkan Oltander
Ansvarig utgivare